GeneRead QIAact Lung DNA Panel
For lung cancer insights from FFPE and liquid biopsy samples
All mutation types: SNVs, InDels and CNVs and fusions*
Developed in collaboration with world top lung cancer experts
Higher sensitivity and more uniform coverage with the unique UMI technology
For use with FFPE and Liquid Biopsy samples
Integrated as part of a complete sample-to-insight NGS workflow including full bioinformatics analysis and interpretation
Lung cancers are characterized by abundant genetic diversity, typically requiring the application of multiple assays in order to achieve cancer research insights. The GeneRead QIAact Lung DNA panel is the first targeted gene panel to consolidate all relevant mutations into a single NGS assay.
The selection of the panel’s 550 variants across 19 genes, was guided by the Lung Cancer Alliance; an international team of lung cancer research specialists, to ensure an assay of unparalleled relevance. The first of the QIAact panel family to incorporate QIAGEN’s Unique Molecular Index (UMI) technology, this panel offers more accurate quantification and detection of molecular variants on the GeneReader than ever before, from as little as 40 ng of input DNA.
Please note: this kit contains regents required for both the target enrichment and library preparation steps of the GeneReader NGS System workflow.
*coming soon
Buy Products
Product Details
Product Resources
Cat No./ID: 181930
GeneRead QIAact Lung DNA panel
Inquire
Two primer mixes, each containing up to 200 primers designed to enrich selected actionable lung cancer associated genes and regions using 40 ng of DNA.
